The global market for Preclinical Imaging Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Preclinical imaging solutions refer to a range of imaging techniques and systems specifically designed for non-invasive imaging and analysis of animals in preclinical research studies. These imaging solutions are used to visualize, study, and quantify biological processes and diseases in small laboratory animals, such as mice and rats, prior to human clinical trials. They play a crucial role in various fields, including pharmaceutical development, biomedical research, and drug discovery.
North American market for Preclinical Imaging Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Preclinical Imaging Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Preclinical Imaging Solution in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Preclinical Imaging Solution include Bruker, PerkinElmer, MILabs, MR Solutions, Aspect Imaging, Mediso, Fujifilm, Siemens Healthineers, TriFoil Imaging, Miltenyi Biotec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preclinical Imaging Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Imaging Solution.
The Preclinical Imaging Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Preclinical Imaging Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Imaging Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Bruker
PerkinElmer
MILabs
MR Solutions
Aspect Imaging
Mediso
Fujifilm
Siemens Healthineers
TriFoil Imaging
Miltenyi Biotec
LI-COR Biosciences
Biospace Lab
Inviscan
Charles River
Minerva Imaging
Segment by Type
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)
Single-Photon Emission Computed Tomography (SPECT)
Others
Segment by Application
Hospital
Diagnostic Center
Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical Imaging Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Preclinical Imaging Solution 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Magnetic Resonance Imaging (MRI)
1.2.3 Computed Tomography (CT)
1.2.4 Positron Emission Tomography (PET)
1.2.5 Single-Photon Emission Computed Tomography (SPECT)
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global Preclinical Imaging Solution 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Laboratory
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical Imaging Solution 麻豆原创 Perspective (2020-2031)
2.2 Global Preclinical Imaging Solution Growth Trends by Region
2.2.1 Global Preclinical Imaging Solution 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Preclinical Imaging Solution Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Preclinical Imaging Solution Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Preclinical Imaging Solution 麻豆原创 Dynamics
2.3.1 Preclinical Imaging Solution Industry Trends
2.3.2 Preclinical Imaging Solution 麻豆原创 Drivers
2.3.3 Preclinical Imaging Solution 麻豆原创 Challenges
2.3.4 Preclinical Imaging Solution 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical Imaging Solution Players by Revenue
3.1.1 Global Top Preclinical Imaging Solution Players by Revenue (2020-2025)
3.1.2 Global Preclinical Imaging Solution Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Preclinical Imaging Solution 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Preclinical Imaging Solution Revenue
3.4 Global Preclinical Imaging Solution 麻豆原创 Concentration Ratio
3.4.1 Global Preclinical Imaging Solution 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Imaging Solution Revenue in 2024
3.5 Global Key Players of Preclinical Imaging Solution Head office and Area Served
3.6 Global Key Players of Preclinical Imaging Solution, Product and Application
3.7 Global Key Players of Preclinical Imaging Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical Imaging Solution Breakdown Data by Type
4.1 Global Preclinical Imaging Solution Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Preclinical Imaging Solution Forecasted 麻豆原创 Size by Type (2026-2031)
5 Preclinical Imaging Solution Breakdown Data by Application
5.1 Global Preclinical Imaging Solution Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Preclinical Imaging Solution Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Preclinical Imaging Solution 麻豆原创 Size (2020-2031)
6.2 North America Preclinical Imaging Solution 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Preclinical Imaging Solution 麻豆原创 Size by Country (2020-2025)
6.4 North America Preclinical Imaging Solution 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical Imaging Solution 麻豆原创 Size (2020-2031)
7.2 Europe Preclinical Imaging Solution 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Preclinical Imaging Solution 麻豆原创 Size by Country (2020-2025)
7.4 Europe Preclinical Imaging Solution 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Imaging Solution 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Preclinical Imaging Solution 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Preclinical Imaging Solution 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Preclinical Imaging Solution 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical Imaging Solution 麻豆原创 Size (2020-2031)
9.2 Latin America Preclinical Imaging Solution 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Preclinical Imaging Solution 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Preclinical Imaging Solution 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Imaging Solution 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Preclinical Imaging Solution 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Preclinical Imaging Solution 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Preclinical Imaging Solution 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bruker
11.1.1 Bruker Company Details
11.1.2 Bruker Business Overview
11.1.3 Bruker Preclinical Imaging Solution Introduction
11.1.4 Bruker Revenue in Preclinical Imaging Solution Business (2020-2025)
11.1.5 Bruker Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Preclinical Imaging Solution Introduction
11.2.4 PerkinElmer Revenue in Preclinical Imaging Solution Business (2020-2025)
11.2.5 PerkinElmer Recent Development
11.3 MILabs
11.3.1 MILabs Company Details
11.3.2 MILabs Business Overview
11.3.3 MILabs Preclinical Imaging Solution Introduction
11.3.4 MILabs Revenue in Preclinical Imaging Solution Business (2020-2025)
11.3.5 MILabs Recent Development
11.4 MR Solutions
11.4.1 MR Solutions Company Details
11.4.2 MR Solutions Business Overview
11.4.3 MR Solutions Preclinical Imaging Solution Introduction
11.4.4 MR Solutions Revenue in Preclinical Imaging Solution Business (2020-2025)
11.4.5 MR Solutions Recent Development
11.5 Aspect Imaging
11.5.1 Aspect Imaging Company Details
11.5.2 Aspect Imaging Business Overview
11.5.3 Aspect Imaging Preclinical Imaging Solution Introduction
11.5.4 Aspect Imaging Revenue in Preclinical Imaging Solution Business (2020-2025)
11.5.5 Aspect Imaging Recent Development
11.6 Mediso
11.6.1 Mediso Company Details
11.6.2 Mediso Business Overview
11.6.3 Mediso Preclinical Imaging Solution Introduction
11.6.4 Mediso Revenue in Preclinical Imaging Solution Business (2020-2025)
11.6.5 Mediso Recent Development
11.7 Fujifilm
11.7.1 Fujifilm Company Details
11.7.2 Fujifilm Business Overview
11.7.3 Fujifilm Preclinical Imaging Solution Introduction
11.7.4 Fujifilm Revenue in Preclinical Imaging Solution Business (2020-2025)
11.7.5 Fujifilm Recent Development
11.8 Siemens Healthineers
11.8.1 Siemens Healthineers Company Details
11.8.2 Siemens Healthineers Business Overview
11.8.3 Siemens Healthineers Preclinical Imaging Solution Introduction
11.8.4 Siemens Healthineers Revenue in Preclinical Imaging Solution Business (2020-2025)
11.8.5 Siemens Healthineers Recent Development
11.9 TriFoil Imaging
11.9.1 TriFoil Imaging Company Details
11.9.2 TriFoil Imaging Business Overview
11.9.3 TriFoil Imaging Preclinical Imaging Solution Introduction
11.9.4 TriFoil Imaging Revenue in Preclinical Imaging Solution Business (2020-2025)
11.9.5 TriFoil Imaging Recent Development
11.10 Miltenyi Biotec
11.10.1 Miltenyi Biotec Company Details
11.10.2 Miltenyi Biotec Business Overview
11.10.3 Miltenyi Biotec Preclinical Imaging Solution Introduction
11.10.4 Miltenyi Biotec Revenue in Preclinical Imaging Solution Business (2020-2025)
11.10.5 Miltenyi Biotec Recent Development
11.11 LI-COR Biosciences
11.11.1 LI-COR Biosciences Company Details
11.11.2 LI-COR Biosciences Business Overview
11.11.3 LI-COR Biosciences Preclinical Imaging Solution Introduction
11.11.4 LI-COR Biosciences Revenue in Preclinical Imaging Solution Business (2020-2025)
11.11.5 LI-COR Biosciences Recent Development
11.12 Biospace Lab
11.12.1 Biospace Lab Company Details
11.12.2 Biospace Lab Business Overview
11.12.3 Biospace Lab Preclinical Imaging Solution Introduction
11.12.4 Biospace Lab Revenue in Preclinical Imaging Solution Business (2020-2025)
11.12.5 Biospace Lab Recent Development
11.13 Inviscan
11.13.1 Inviscan Company Details
11.13.2 Inviscan Business Overview
11.13.3 Inviscan Preclinical Imaging Solution Introduction
11.13.4 Inviscan Revenue in Preclinical Imaging Solution Business (2020-2025)
11.13.5 Inviscan Recent Development
11.14 Charles River
11.14.1 Charles River Company Details
11.14.2 Charles River Business Overview
11.14.3 Charles River Preclinical Imaging Solution Introduction
11.14.4 Charles River Revenue in Preclinical Imaging Solution Business (2020-2025)
11.14.5 Charles River Recent Development
11.15 Minerva Imaging
11.15.1 Minerva Imaging Company Details
11.15.2 Minerva Imaging Business Overview
11.15.3 Minerva Imaging Preclinical Imaging Solution Introduction
11.15.4 Minerva Imaging Revenue in Preclinical Imaging Solution Business (2020-2025)
11.15.5 Minerva Imaging Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Bruker
PerkinElmer
MILabs
MR Solutions
Aspect Imaging
Mediso
Fujifilm
Siemens Healthineers
TriFoil Imaging
Miltenyi Biotec
LI-COR Biosciences
Biospace Lab
Inviscan
Charles River
Minerva Imaging
听
听
*If Applicable.
